A detailed history of Blair William & CO transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Blair William & CO holds 157,500 shares of PDSB stock, worth $245,700. This represents 0.0% of its overall portfolio holdings.

Number of Shares
157,500
Previous 121,743 29.37%
Holding current value
$245,700
Previous $465,000 44.95%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$1.63 - $4.11 $58,283 - $146,961
35,757 Added 29.37%
157,500 $256,000
Q2 2024

Aug 12, 2024

BUY
$2.55 - $4.02 $208,444 - $328,606
81,743 Added 204.36%
121,743 $356,000
Q1 2024

May 09, 2024

BUY
$3.85 - $6.59 $154,000 - $263,600
40,000 New
40,000 $158,000

Others Institutions Holding PDSB

About PDS Biotechnology Corp


  • Ticker PDSB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,458,700
  • Market Cap $44.4M
  • Description
  • PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...
More about PDSB
Track This Portfolio

Track Blair William & CO Portfolio

Follow Blair William & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.